|  | Cancer | Pancreatic Cancer

Exocrine Pancreatic Insufficiency (EPI): Causes, Symptoms, and Management

Understanding Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency (EPI) occurs when the pancreas fails to produce sufficient digestive enzymes—lipase, protease, and amylase—leading to maldigestion and malabsorption of fats, proteins, and carbohydrates.

Common Causes

  • Chronic pancreatitis (leading cause in adults)
  • Cystic fibrosis (leading cause in children; ~90% develop EPI)
  • Pancreatic cancer or resection (Whipple procedure, total pancreatectomy)
  • Diabetes mellitus (Type 1 and 2; pancreatic atrophy and neuropathy)
  • Celiac disease, Crohn's disease, Zollinger-Ellison syndrome
  • Medications: Long-term proton pump inhibitors (controversial); octreotide
  • Genetic disorders: Shwachman-Diamond syndrome, Johanson-Blizzard syndrome

Symptoms (Often Subtle Initially)

  • Unintentional weight loss
  • Chronic diarrhea or loose, urgent stools
  • Steatorrhea: Pale, bulky, foul-smelling, floating, oily stools that adhere to the toilet bowl
  • Abdominal pain, bloating, and gas (worse after meals)
  • Fatigue and muscle wasting
  • Fat-soluble vitamin deficiencies (A, D, E, K) causing night blindness, osteopenia, coagulopathy, neuropathy
  • Vitamin B12 deficiency (impaired intrinsic factor protection)

Diagnosis

  • Fecal elastase-1: <200 µg/g (moderate), <100 µg/g (severe). Non-invasive, first-line test.
  • 72-hour fecal fat quantification: Gold standard but cumbersome (>7 g/day abnormal).
  • Serum vitamin levels: Vitamins A, D, E, K, B12, prealbumin.
  • Imaging: CT, MRCP, or EUS for structural causes (calcifications, atrophy, mass).
  • Secretin stimulation test: Rarely used; functional gold standard.

Treatment: Pancreatic Enzyme Replacement Therapy (PERT)

  • Enteric-coated microspheres (Creon, Zenpep, Pancreaze, Pertzye, Viokace) protect enzymes from gastric acid.
  • Dosing: Weight-based + meal size/fat content. Typical start: 40,000–50,000 lipase units/meal; 25,000/snack. Titrate to symptom control.
  • Administration: With first bite; spread throughout meal. Swallow whole—do not crush or chew.
  • Acid suppression: PPI or H2 blocker often co-prescribed to optimize duodenal pH for enzyme activity.
  • Nutritional support: Small, frequent meals; moderate fat (not low-fat—fat stimulates enzyme secretion); MCT oil if severe; vitamin supplementation (ADEK + B12).

Monitoring and Follow-Up

  • Symptom review every 3–6 months
  • Weight, stool quality, vitamin levels annually
  • Adjust PERT for weight changes, surgery, or disease progression

With proper PERT and nutritional management, most EPI patients achieve normal digestion, stable weight, and excellent quality of life.

Pancreatic Cancer - Related Articles